|
Market Closed -
Bombay S.E.
11:02:26 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 12.12 INR | +2.71% |
|
-6.12% | -15.24% |
| Market Cap | 1.73B 18.35M 15.79M 14.85M 13.57M 25.38M 25.45M 176M 68.11M 889M 68.89M 67.39M 2.86B | P/E 2024 |
26x | P/E 2025 | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.46B 15.44M 13.28M 12.5M 11.42M 21.36M 21.41M 148M 57.31M 748M 57.97M 56.7M 2.41B | EV / Sales 2024 |
3.67x | EV / Sales 2025 | 1.79x |
| Free-Float |
63.52% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.71% | ||
| 1 week | -6.12% | ||
| Current month | -3.96% | ||
| 1 month | +36.18% | ||
| 3 months | +14.12% | ||
| 6 months | +8.02% | ||
| Current year | -15.24% |
| 1 week | 11.7 | 12.99 | |
| 1 month | 8.75 | 13.25 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 17.25 | |
| 3 years | 7.05 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 | |
| Director/Board Member | - | 20/12/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.71% | -6.12% | +6.78% | +51.31% | 31.19M | ||
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | ||
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | ||
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | ||
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | ||
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | ||
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | ||
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | ||
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | ||
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | ||
| Average | -0.57% | +0.37% | +26.47% | +52.23% | 367.84B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 867M 9.18M 7.9M 7.44M 6.79M 12.71M 12.74M 87.87M 34.1M 445M 34.49M 33.74M 1.43B | 1.38B 14.61M 12.57M 11.83M 10.8M 20.21M 20.26M 140M 54.22M 708M 54.85M 53.65M 2.28B |
| Net income | 132M 1.4M 1.2M 1.13M 1.03M 1.93M 1.94M 13.35M 5.18M 67.6M 5.24M 5.13M 218M | 181M 1.92M 1.65M 1.55M 1.42M 2.66M 2.66M 18.36M 7.13M 92.98M 7.21M 7.05M 300M |
| Net Debt | -413M -4.37M -3.76M -3.54M -3.23M -6.05M -6.07M -41.84M -16.24M -212M -16.42M -16.07M -683M | -275M -2.91M -2.5M -2.36M -2.15M -4.03M -4.04M -27.84M -10.8M -141M -10.93M -10.69M -454M |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ₹12.12 | +2.71% | 320,497 |
| 03/09/26 | ₹11.80 | -1.99% | 283,127 |
| 02/09/26 | ₹12.04 | -0.50% | 535,384 |
| 01/09/26 | ₹12.10 | -4.12% | 658,584 |
| 31/08/26 | ₹12.62 | -2.25% | 491,430 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















